Selective inhibition of SphK1 by VPC96091, induces the reduction of epidermal growth factor (EGF), which drives S1P levels and then increases Akt/ERK phosphorylation in human leukemia U937 cells and mice model. This evidence concerns the gene EGF and leukemia.